Helicobacter pylori-Mediated Oxidative Stress and Gastric Diseases: A Review

L Han, X Shu, J Wang - Frontiers in Microbiology, 2022 - frontiersin.org
Gastric cancer is considered to be a type of gastrointestinal tumor and is mostly
accompanied by Helicobacter pylori (HP) infection at the early stage. Hence, the long-term …

Future Perspective for Potential Helicobacter Pylori Eradication Therapies

A Debraekeleer, H Remaut - Future microbiology, 2018 - Taylor & Francis
Helicobacter pylori infection of the human stomach causes chronic inflammation and forms a
major risk factor for the development of peptic ulcer disease and gastric cancer. Current …

The coordinated action of the enzymes in the L-lysine biosynthetic pathway and how to inhibit it for antibiotic targets

S Muduli, S Karmakar, S Mishra - Biochimica et Biophysica Acta (BBA) …, 2023 - Elsevier
Background Antimicrobial resistance is a global health issue that requires immediate
attention in terms of new antibiotics and new antibiotic targets. The l-lysine biosynthesis …

Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens

S Salillas, J Sancho - International Journal of Molecular Sciences, 2020 - mdpi.com
Flavodoxins are small soluble electron transfer proteins widely present in bacteria and
absent in vertebrates. Flavodoxins participate in different metabolic pathways and, in some …

Deciphering the possible role of ctxB7 allele on higher production of cholera toxin by Haitian variant Vibrio cholerae O1

A Naha, RS Mandal, P Samanta, RN Saha… - PLoS neglected …, 2020 - journals.plos.org
Cholera continues to be an important public health concern in developing countries where
proper hygiene and sanitation are compromised. This severe diarrheal disease is caused by …

Practical spectrophotometric assay for the dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase, a potential antibiotic target

TK Heath, MR Lutz Jr, CT Reidl, ER Guzman… - PloS one, 2018 - journals.plos.org
A new enzymatic assay for the bacterial enzyme succinyl-diaminopimelate desuccinylase
(DapE, EC 3.5. 1.18) is described. This assay employs N 6-methyl-N 2-succinyl-L, L …

Indoline-6-sulfonamide inhibitors of the bacterial enzyme DapE

CT Reidl, TK Heath, I Darwish, RM Torrez, M Moore… - Antibiotics, 2020 - mdpi.com
Inhibitors of the bacterial enzyme dapE-encoded N-succinyl-l, l-diaminopimelic acid
desuccinylase (DapE; EC 3.5. 1.18) hold promise as antibiotics with a new mechanism of …

The three-dimensional structure of DapE from Enterococcus faecium reveals new insights into DapE/ArgE subfamily ligand specificity

M Terrazas-López, L González-Segura… - International Journal of …, 2024 - Elsevier
DapE is a Zn 2+-metallohydrolase recognized as a drug target for bacterial control. It is a
homodimer that requires the exchange of interface strands by an induced fit essential for …

Atomic-resolution 1.3 Å crystal structure, inhibition by sulfate, and molecular dynamics of the bacterial enzyme DapE

M Kochert, BP Nocek, TS Habeeb Mohammad… - Biochemistry, 2021 - ACS Publications
We report the atomic-resolution (1.3 Å) X-ray crystal structure of an open conformation of the
dapE-encoded N-succinyl-l, l-diaminopimelic acid desuccinylase (DapE, EC 3.5. 1.18) from …

Genome Subtraction and Comparison for the Identification of Novel Drug Targets against Mycobacterium avium subsp. hominissuis

R Uddin, B Siraj, M Rashid, A Khan, S Ahsan Halim… - Pathogens, 2020 - mdpi.com
Mycobacterium avium complex (MAC) is a major cause of non-tuberculous pulmonary and
disseminated diseases worldwide, inducing bronchiectasis, and affects HIV and …